Spectranetics Corporation: Clinical Trials

1 trial sponsored by Spectranetics Corporation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Spectranetics Corporation: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study
StellarexTM 0.014" Over-The-Wire Drug-coated Angioplasty Balloon - Peripheral Arterial Disease
Phase 4CompletedSpectranetics Corporation492018-04-202024-01-24

Conditions studied

Chronic Limb-Threatening Ischemia (1)  ·  Intermittent Claudication (1)  ·  Peripheral Arterial Disease (1)

Countries

Germany (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Gunnar Tepe, MD (1)